Not applicableStudy completedNCT03911284What this trial is testingThe Learning RegistryWho this might be right forAtherosclerotic Cardiovascular Disease Duke University 2,000
Not applicableEnded earlyNCT05834673What this trial is testingVICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)Who this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more Monash University 6
Not applicableStudy completedNCT05362903What this trial is testingA Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world SettingWho this might be right forHypercholesterolemia Novartis Pharmaceuticals 1,868
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013What this trial is testingInvestigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)Who this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a) Eli Lilly and Company 17,300
Early research (Phase 1)Study completedNCT05091073What this trial is testingA Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy ParticipantsWho this might be right forEstablished Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD RiskElevated CholesterolHealthy Volunteers Novo Nordisk A/S 73
Not applicableStudy completedNCT07141914What this trial is testingA Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real WorldWho this might be right forOverweightObesityHeart Failure (HF)+2 more Novo Nordisk A/S 285,327
Not applicableUnknownNCT06406998What this trial is testingMaternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVDWho this might be right forCardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more Samsung Medical Center 5,461,222
Post-approval studies (Phase 4)UnknownNCT05976893What this trial is testingStudy on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and CancerWho this might be right forASCVDAtherosclerotic Cardiovascular DiseaseProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor+1 more Xiang Xie 620
Testing effectiveness (Phase 2)Looking for participantsNCT07487363What this trial is testingTB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDWho this might be right forAtherosclerotic Cardiovascular DiseasesEndothelial Dysfunction Hudson Biotech 80
Not applicableStudy completedNCT07160829What this trial is testingFocus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure ManagementWho this might be right forAtherosclerotic Cardiovascular DiseaseHeart FailureChronic Kidney Disease Novo Nordisk A/S 608
Large-scale testing (Phase 3)Study completedNCT06267560What this trial is testingLp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDWho this might be right forElevated Lp(a) and Established Atherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 422
Post-approval studies (Phase 4)Study completedNCT03597412What this trial is testingRosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DMWho this might be right forAtherosclerotic Cardiovascular DiseaseType 2 Diabetes Mellitus Yuhan Corporation 236
Not applicableLooking for participantsNCT07743021What this trial is testingHealth for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding DataWho this might be right forNon-communicable Diseases (NCD)NeoplamsCancer+11 more Center for Molecular Fingerprinting Research Nonprofit LLC 15,000
Not applicableUnknownNCT05031377What this trial is testingEffects of Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of ASCVDWho this might be right forCardiovascular DiseasesHealthy LifestyleHealth Education The Hong Kong Polytechnic University 80
Not applicableNot Yet RecruitingNCT07208331What this trial is testingEvaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk ManagementWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)HypertensionDyslipidemia Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 750
Testing effectiveness (Phase 2)Study completedNCT05563246What this trial is testingLY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsWho this might be right forLipoprotein Disorder Eli Lilly and Company 233
Not applicableStudy completedNCT06322641What this trial is testingUnderstand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among NephrologistsWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)Systemic Inflammation Novo Nordisk A/S 300
Not applicableLooking for participantsNCT06960902What this trial is testingStudy of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)Who this might be right forFamilial HypercholesterolemiasAtherosclerotic Cardiovascular Disease (ASCVD) Nantes University Hospital 600
Post-approval studies (Phase 4)Study completedNCT05761444What this trial is testingEffectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk PatientsWho this might be right forAtherosclerotic Cardiovascular Disease Organon and Co 137
Not applicableStudy completedNCT07196280What this trial is testingProtective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database StudiesWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Benign Prostatic Hypertrophy (BPH) Chinese PLA General Hospital 10,000